8-K - Ocugen, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Ocugen closed a registered direct offering in August 2025 for 20,000,000 shares of common stock and warrants to purchase up to 20,000,000 shares. On March 12, 2026, the Investor partially exercised the warrants, purchasing 10,000,000 shares for gross proceeds of $15.0 million, anticipated to extend Ocugen's cash runway into the first quarter of 2027.

Key Takeaways

1Institutional Investor partially exercised warrants on March 12, 2026, purchasing 10,000,000 shares of Common Stock.

2Gross proceeds from partial warrant exercise: $15.0 million.

3August 2025 registered direct offering: 20,000,000 shares of Common Stock ($0.01 par value) and warrants for 20,000,000 shares.

4Proceeds expected to extend cash runway into first quarter of 2027.

Current Report Details

Event Type

Other Event

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. As previously disclosed, in August 2025, Ocugen, Inc. (“Ocugen”) closed a registered direct offering, pursuant to a securities purchase agreement

Other Event

$15.0M

Exhibits (1)

8-K

FORM 8-K